Qu; Kevin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Qu; Kevin.The latest application filed is for "compositions and methods for screening mutations in thyroid cancer".

Company Profile

9.11.18

Qu; Kevin - Lake Forest CA
QU; Kevin - San Juan Capistrano CA
Qu; Kevin - US
Qu; Kevin - Irvine CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Circulating microRNA as a marker for hepatocellular carcinoma Grant 11,421,283 - Qu , et al. August 23, 2	2022-08-23
Compositions And Methods For Screening Mutations In Thyroid Cancer App 20210324468 - CHENG; Shih-Min ; et al.	2021-10-21
Methods Of Detecting Mlh1 Methylation App 20210254172 - Qu; Kevin ; et al.	2021-08-19
Compositions and methods for screening mutations in thyroid cancer Grant 11,053,542 - Cheng , et al. July 6, 2	2021-07-06
Microrna Profiling For Diagnosis Of Dysplastic Nevi And Melanoma App 20210147947 - Qu; Kevin ; et al.	2021-05-20
Methods of detecting MLH1 methylation Grant 10,982,288 - Qu , et al. April 20, 2	2021-04-20
Compositions And Methods For Screening Solid Tumors App 20200385817 - Sanders; Heather ; et al.	2020-12-10
MicroRNA profiling for diagnosis of dysplastic nevi and melanoma Grant 10,851,424 - Qu , et al. December 1, 2	2020-12-01
Methods for screening solid tumors for mutations Grant 10,689,710 - Sanders , et al.	2020-06-23
Circulating Microrna As A Marker For Hepatocellular Carcinoma App 20200115759 - Qu; Kevin ; et al.	2020-04-16
Circulating microRNA as a marker for hepatocellular carcinoma Grant 10,422,010 - Qu , et al. Sept	2019-09-24
Methods Of Detecting Mlh1 Methylation App 20190177805 - Qu; Kevin ; et al.	2019-06-13
Compositions And Methods For Screening Mutations In Thyroid Cancer App 20190112653 - CHENG; Shih-Min ; et al.	2019-04-18
Microrna Profiling For Diagnosis Of Dysplastic Nevi And Melanoma App 20190062844 - Qu; Kevin ; et al.	2019-02-28
MicroRNA profiling for diagnosis of dysplastic nevi and melanoma Grant 10,053,738 - Qu , et al. August 21, 2	2018-08-21
Circulating Microrna As A Marker For Hepatocellular Carcinoma App 20180163274 - Qu; Kevin ; et al.	2018-06-14
Microrna profiling for diagnosis of dysplastic nevi and melanoma Grant 9,988,689 - Qu , et al. June 5, 2	2018-06-05
Compositions And Methods For Screening Solid Tumors App 20180142304 - SANDERS; Heather ; et al.	2018-05-24
Circulating microRNA as a marker for hepatocellular carcinoma Grant 9,840,741 - Qu , et al. December 12, 2	2017-12-12
Microrna Profiling For Diagnosis Of Dysplastic Nevi And Melanoma App 20170088899 - Qu; Kevin ; et al.	2017-03-30
Microrna Profiling For Diagnosis Of Dysplastic Nevi And Melanoma App 20170081725 - Qu; Kevin ; et al.	2017-03-23
Microrna profiling for diagnosis of dysplastic nevi and melanoma Grant 9,447,471 - Qu , et al. September 20, 2	2016-09-20
Microrna Profiling For Diagnosis Of Dysplastic Nevi And Melanoma App 20130196869 - Qu; Kevin ; et al.	2013-08-01
Circulating Microrna As A Marker For Hepatocellular Carcinoma App 20110281268 - Qu; Kevin ; et al.	2011-11-17
Ubiquitin Proteasome System Profiling For Diagnosis Of Chronic Liver Disease App 20110269162 - Albitar; Maher ; et al.	2011-11-03
Circulating Microrna As A Marker For Hepatocellular Carcinoma App 20110223607 - Qu; Kevin ; et al.	2011-09-15
Ubiquitin Proteasome System Profiling And The Use Thereof In Clinical Applications For Cancer Diagnosis App 20110053199 - Albitar; Maher ; et al.	2011-03-03
Ubiquitin Proteasome System Profiling And The Use Thereof In Clinical Applications For Cancer Diagnosis App 20110053197 - Albitar; Maher ; et al.	2011-03-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.